# Fruzaqla

NDC: 63020-210
Generic name: fruquintinib
Labeler / Manufacturer: Takeda Pharmaceuticals America, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20231108

FDA application: NDA217564

## Active ingredients

- FRUQUINTINIB: 1 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63020-210"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63020-210
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=186d786e-dc8a-45f2-b5e1-01ac0201879f